D. Western Therapeutics Institute (TSE:4576) Notes Receivable: 円0.00 Mil (As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
44 GF Score
Price 円83.00
GF Value 円63.99
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Notes Receivable?

D. Western Therapeutics Institute TSE:4576 +5.06% 44 Notes Receivable is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 44/100 and a GF Value™ of 円63.99 (Modestly Overvalued). The stock has 3 warning signs investors should review.

D. Western Therapeutics Institute's Notes Receivable for the quarter that ended in Dec. 2025 was 円0.00 Mil.

D. Western Therapeutics Institute Notes Receivable Related Terms

D. Western Therapeutics Institute Notes Receivable Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Notes Receivable Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4576
44GF Score
D. Western Therapeutics Institute Inc TSE:4576
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of 円0.00 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Notes Receivable of 円0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Notes Receivable too high?
D. Western Therapeutics Institute's current Notes Receivable is 円0.00 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Notes Receivable compare to VRTX and REGN?
D. Western Therapeutics Institute's Notes Receivable of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Notes Receivable is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Modestly Overvalued. The stock's GF Value™ is 円63.99, compared to a current price of 円83.00 — trading 29.7% above its estimated fair value. The current Notes Receivable is 円0.00 Mil. D. Western Therapeutics Institute's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Notes Receivable is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円83.00 is trading 29.7% above its estimated GF Value™ of 円63.99. GuruFocus considers D. Western Therapeutics Institute to be Modestly Overvalued.

Key valuation signals for TSE:4576:

  • Notes Receivable: 円0.00 Mil
  • GF Value™: 円63.99 vs. price of 円83.00 (29.7% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
44GF Score

Get the complete analysis for TSE:4576

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円83.00
Price
円63.99
GF Value